Covishield is ready for roll-out in the coming weeks , said Adar Poonawalla. (File photo)
New Delhi:
All the risks taken by Serum Institute have finally paid off, tweeted Adar Poonawalla, the chief executive of the Pune-based vaccine manufacturer, shortly after the country s drug regulator cleared its Covishield vaccine for emergency approval in India. Mr Poonawalla reiterated that the Covishield vaccine developed by Serum Institute of India in partnership with the Oxford University and pharma major AstraZeneca - is safe and effective against coronavirus and added that the vaccine is ready to roll out in the coming weeks .
Mr Poonawalla, CEO of the Serum Institute, said to be the world s largest vaccine maker, had earlier said the majority of the first 50 million doses will go to India .